Paul A Skopec, MD | |
1200 1st Ave E, Box 71, Spencer, IA 51301-4342 | |
(712) 262-7511 | |
Not Available |
Full Name | Paul A Skopec |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1200 1st Ave E, Spencer, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770543332 | NPI | - | NPPES |
43439 | Other | BCBS OF IOWA | |
7096289 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 28551 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Paul A Skopec, MD 1200 1st Ave E, P O Box 71, Spencer, IA 51301-4342 Ph: (712) 262-7511 | Paul A Skopec, MD 1200 1st Ave E, Box 71, Spencer, IA 51301-4342 Ph: (712) 262-7511 |
News Archive
It's well known that keeping blood glucose levels in check can help individuals avoid or manage diabetes, but new research led by biologists at The University of Texas at Dallas suggests that restricting blood glucose levels might also keep certain cancers at bay.
A new project for the early detection of Parkinson's disease with strongly magnetized xenon gas has been initiated at FMP. The team led by physicist Leif Schröder has received a three-year grant from the Michael J. Fox Foundation for Parkinson's Research.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.
Nearly one in 11 Americans will have a kidney stone in their lifetime, causing pain, sometimes missed work and, often, a lot of money.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.
› Verified 4 days ago
Dr. Charles Allen Crouch, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1200 1st Ave E, Suite C, Spencer, IA 51301 Phone: 712-262-7511 Fax: 712-262-3658 |